Market News AIOpen the app

BLRX stock news · BioLineRx Ltd.

Stories about BioLineRx Ltd. (BLRX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for BLRX

Follow BioLineRx Ltd. (BLRX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for BLRX
Free on the App Store and Google Play, or on the web.
  1. Nov 19, 2026, 2:04 AM ET · Market

    BioLineRx will share its third quarter 2026 financial results on November 23, 2026.

    Neutral

    BioLineRx set November 23, 2026, for its third-quarter report and call. The notice gives no financial results, so it does not change the company’s outlook.

  2. Oct 24, 2026, 2:10 AM ET · Market

    BioLineRx and Hemispherian shared new research at ESMO 2026 showing GLIX1 works well with PARP inhibitors.

    Good for BLRX

    BioLineRx reported promising GLIX1 results with PARP inhibitors in ovarian cancer models. The findings support a possible new treatment use, but it still needs study in people.

  3. Sep 30, 2026, 5:30 PM ET · Market

    12 health care stocks are changing in price during Wednesday's after-hours trading.

    Neutral

    BioLine Rx shares fell 7.2% after hours. The story gives no company update, so this move alone does not change its outlook.